EUVIMEDEUVIMED entdecken
Klinische Studie

Single-Port Robotic Trans-Subxiphoid Surgery for Anterior Mediastinal Disease: A Pilot Trial

Chuan Cheng, Evangelos Tagkalos, Chong Beng Ng iD, Ya-Chun Hsu, Yu Ya Huang, Ching Feng Wu, Yin-Kai Chao iD

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2024-05 · 19 (3) · 268-273

DOI: 10.1177/15569845241248641 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 09.05.2024. Verfasst von Chuan Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, New Taipei Municipal Tu-Cheng Hospital, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Mediastinal Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: chang gung memorial hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In recent years, there has been an increasing focus on minimally invasive mediastinal surgery using a trans-subxiphoid single-port thoracoscopic approach. Despite its potential advantages, the widespread adoption of this method has been hindered by the intricate surgical maneuvers required within the confined retrosternal space. Robotic surgery offers the potential to overcome the limitations inherent in the thoracoscopic technique.

Methods

This was a clinical trial (NCT05455840) to evaluate the feasibility and safety of utilizing the da Vinci ® SP system (Intuitive Surgical, Sunnyvale, CA, USA) for trans-subxiphoid single-port surgery in patients with anterior mediastinal disease. The primary endpoints encompassed conversion rates and the secondary endpoints included the occurrence of perioperative complications.

Results

Between August 2022 and April 2023, a total of 15 patients (7 men and 8 women; median age = 56 years, interquartile range [IQR]: 49 to 65 years) underwent trans-subxiphoid robotic surgery using da Vinci SP platform for maximal thymectomy ( n = 2) or removal of anterior mediastinal masses ( n = 13). All surgical procedures were carried out with success, with no need for conversion to open surgery or the creation of additional ports. The median docking time was 2 min (IQR: 1 to 4 min), while the console time had a median of 152 min (IQR: 95 to 191 min). There were no postoperative complications and patients experienced a median postoperative hospital stay of 2 days with no unplanned 30-day readmission.

Conclusions

This study shows that trans-subxiphoid single-port robotic surgery employing the da Vinci SP system in patients with anterior mediastinal disease is clinically viable with acceptable safety and short-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresMediastinal DiseasesHumansFemaleMaleMiddle AgedPilot ProjectsAgedThymectomyFeasibility StudiesPostoperative ComplicationsTreatment OutcomeOperative TimeLength of StayThoracoscopy

Stichwörter der Autor:innen

anterior mediastinal diseaserobot-assisted surgerysingle-portthymectomytrans-subxiphoid approach

Autor:innen und Institutionen

  • Division of Thoracic Surgery, New Taipei Municipal Tu-Cheng Hospital, New Taipei City, Taiwan.
  • Division of Thoracic Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Germany.
  • Department of Upper Gastrointestinal Surgery, National Cancer Institute, Putrajaya, Malaysia.
  • Department of Nursing, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Department of Marketing, Intuitive Surgical Sarl Taiwan Branch, Taipei City, Taiwan.

ORCID-Profile: Chong Beng Ng, Yin-Kai Chao

Förderung

  • chang gung memorial hospital

Zitieren

APA

Cheng, C., Tagkalos, E., Ng, C. B., Hsu, Y. C., Huang, Y. Y., Wu, C. F., & Chao, Y. K. (2024). Single-Port Robotic Trans-Subxiphoid Surgery for Anterior Mediastinal Disease: A Pilot Trial. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 19(3), 268-273. https://doi.org/10.1177/15569845241248641

Vancouver

Cheng C, Tagkalos E, Ng CB, Hsu YC, Huang YY, Wu CF, et al. Single-Port Robotic Trans-Subxiphoid Surgery for Anterior Mediastinal Disease: A Pilot Trial. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2024;19(3):268-273. doi:10.1177/15569845241248641

BibTeX
@article{Cheng2024,
  author = {Cheng, Chuan and Tagkalos, Evangelos and Ng, Chong Beng and Hsu, Ya-Chun and Huang, Yu Ya and Wu, Ching Feng and Chao, Yin-Kai},
  title = {Single-Port Robotic Trans-Subxiphoid Surgery for Anterior Mediastinal Disease: A Pilot Trial},
  journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
  year = {2024},
  volume = {19},
  number = {3},
  pages = {268--273},
  doi = {10.1177/15569845241248641}
}
Kostenlos starten →